Physician
Quick Med Urgent Care LLC
Quick Med Urgent Care LLC was paid $21.76M by Medicaid between Oct 2019 and Dec 2024, across 107 billing codes. Its largest line is K1034, Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count — 50% of everything it billed.
33Billing provider infoQUICK MED URGENT CARE LLC
YOUNGSTOWN, OH 44505
YOUNGSTOWN, OH 44505
33aNPI1528528726assigned 03/22/2019
33bProvider typeGynecology Physician
28Total paid$21.76M
24GClaims408,761
24DCodes billed107
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers
Next to other Gynecology Physician providers in Ohio
Rank by total paid#1 of 13
Median peer was paid$20K
This provider vs. median1,114×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 2,450 | $53K | |
| 2020 | 37,412 | $1.59M | |
| 2021 | 52,125 | $1.86M | |
| 2022 | 80,881 | $2.63M | |
| 2023 | 103,489 | $6.74M | |
| 2024incomplete | 132,404 | $8.89M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 50% | 127,464 | 121,676 | $10.90M |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 11% | 10,978 | 9,611 | $2.35M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10% | 59,768 | 53,887 | $2.28M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8.0% | 36,415 | 33,915 | $1.75M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.7% | 20,046 | 18,370 | $578K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2.5% | 8,737 | 8,250 | $553K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 1.9% | 3,278 | 3,075 | $414K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.8% | 7,105 | 6,516 | $390K |
| 87428 | 1.2% | 9,001 | 8,039 | $270K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 6,959 | 6,394 | $209K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 9,717 | 9,239 | $199K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 2,703 | 2,398 | $185K |
95 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 3,249 | $150K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 5,386 | $118K |
| 87529 | <1% | 2,541 | $111K | |
| 87640 | <1% | 7,234 | $105K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 8,657 | $92K |
| 87481 | <1% | 2,593 | $88K | |
| 87641 | <1% | 5,178 | $82K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 8,691 | $78K |
| 87634 | <1% | 2,839 | $71K | |
| 87653 | <1% | 2,832 | $61K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,536 | $56K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,530 | $55K |
| 87581 | <1% | 3,586 | $54K | |
| 87541 | <1% | 3,537 | $52K | |
| 87486 | <1% | 3,535 | $52K | |
| 87498 | <1% | 3,219 | $46K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 2,473 | $45K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,813 | $39K |
| 99051 | <1% | 4,782 | $29K | |
| 87511 | <1% | 1,837 | $29K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,645 | $22K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 602 | $22K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 479 | $17K |
| D1120 | Dental cleaning, child | <1% | 617 | $17K |
| 86769 | <1% | 414 | $16K | |
| 86328 | <1% | 743 | $14K | |
| 87500 | <1% | 561 | $13K | |
| 87632 | <1% | 149 | $11K | |
| 87563 | <1% | 258 | $9K | |
| 81025 | <1% | 1,433 | $8K | |
| D1351 | Sealant - per tooth | <1% | 233 | $8K |
| D1206 | Topical application of fluoride varnish | <1% | 471 | $8K |
| 81002 | <1% | 3,542 | $8K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 75 | $7K |
| 99385 | <1% | 115 | $7K | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 247 | $7K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 426 | $7K |
| 80305 | <1% | 822 | $6K | |
| D0272 | Bitewings - two radiographic images | <1% | 479 | $6K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,156 | $5K |
| D0120 | Dental checkup, returning patient | <1% | 233 | $5K |
| 99442 | <1% | 119 | $5K | |
| D0330 | Panoramic radiographic image | <1% | 56 | $4K |
| 81513 | <1% | 73 | $4K | |
| D1110 | Prophylaxis - adult | <1% | 74 | $4K |
| 99386 | <1% | 46 | $4K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 187 | $4K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 129 | $2K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 15 | $2K |
| D0274 | Bitewings - four radiographic images | <1% | 74 | $2K |
| 81514 | <1% | 37 | $2K | |
| 73630 | <1% | 102 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 19 | $2K |
| 84449 | <1% | 125 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 150 | $1K |
| 93000 | <1% | 78 | $1K | |
| 73610 | <1% | 62 | $964.31 | |
| 73130 | <1% | 53 | $962.43 | |
| 80053 | Comprehensive metabolic panel | <1% | 160 | $948.96 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 13 | $915.72 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 14 | $817.20 |
| 76830 | Ultrasound, transvaginal | <1% | 14 | $817.20 |
| 80061 | Lipid panel | <1% | 112 | $785.84 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 12 | $777.84 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 174 | $742.28 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 179 | $686.14 |
| 0012A | <1% | 28 | $634.55 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,208 | $528.48 |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 38 | $517.50 |
| 0011A | <1% | 36 | $462.46 | |
| 83037 | <1% | 87 | $454.25 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 85 | $448.28 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 418 | $441.23 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 95 | $425.76 |
| 80306 | <1% | 77 | $417.57 | |
| 97597 | <1% | 17 | $312.46 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 29 | $296.92 |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 60 | $260.00 |
| 99406 | <1% | 26 | $180.00 | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 33 | $160.00 |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | <1% | 2,492 | $140.00 |
| 69209 | <1% | 16 | $111.53 | |
| 86308 | <1% | 30 | $100.95 | |
| 36416 | <1% | 36 | $83.49 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 79 | $49.45 |
| 82270 | <1% | 12 | $32.90 | |
| 99173 | <1% | 14 | $7.20 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 86 | $5.33 |
| 1159F | 0% | 648 | $0.00 | |
| 99072 | 0% | 1,593 | $0.00 | |
| 90715 | 0% | 13 | $0.00 | |
| 90734 | 0% | 13 | $0.00 | |
| 1036F | 0% | 451 | $0.00 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 17 | $0.00 |
| T1503 | Administration of medication, other than oral and/or injectable, by a health care agency/professional, per visit | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialESMAIL, LENA (OWNER)